Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Novel agents and immune invasion in Hodgkin lymphoma

Reid W. Merryman, Ann LaCasce

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 243–248.

https://doi.org/10.1182/hematology.2019000029

Published: 2019

Journal Articles

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Yohei Hisada, Nigel Mackman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 182–186.

https://doi.org/10.1182/hematology.2019000025

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Measuring success: utility of biomarkers in sickle cell disease clinical trials and care

Ram Kalpatthi, Enrico M. Novelli

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 482–492.

https://doi.org/10.1182/asheducation-2018.1.482

Published: 2018

Journal Articles

GVHD: biology matters

James L. M. Ferrara, Mohammed S. Chaudhry

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 221–227.

https://doi.org/10.1182/asheducation-2018.1.221

Published: 2018

Journal Articles

AL amyloidosis: from molecular mechanisms to targeted therapies

Giampaolo Merlini

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 1–12.

https://doi.org/10.1182/asheducation-2017.1.1

Published: 2017

Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 13–21.

https://doi.org/10.1182/asheducation-2017.1.13

Published: 2017

Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.

https://doi.org/10.1182/asheducation-2017.1.329

Published: 2017

Journal Articles

Classification and risk assessment in AML: integrating cytogenetics and molecular profiling

Matahi Moarii, Elli Papaemmanuil

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 37–44.

https://doi.org/10.1182/asheducation-2017.1.37

Published: 2017

Journal Articles

Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies

Kerry J. Savage

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 578–586.

https://doi.org/10.1182/asheducation-2017.1.578

Published: 2017

Journal Articles

Follicular lymphoma: are we ready for a risk-adapted approach?

Brad S. Kahl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 358–364.

https://doi.org/10.1182/asheducation-2017.1.358

Published: 2017

Journal Articles

Molecular monitoring in chronic myeloid leukemia—how low can you go?

Susan Branford

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 156–163.

https://doi.org/10.1182/asheducation-2016.1.156

Published: 2016

Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.

https://doi.org/10.1182/asheducation-2016.1.269

Published: 2016

Journal Articles

Sickle cell disease: an inherited thrombophilia

Ted Wun, Ann Brunson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 640–647.

https://doi.org/10.1182/asheducation-2016.1.640

Published: 2016

Journal Articles

Hodgkin lymphoma in children and adolescents: improving the therapeutic index

Kara M. Kelly

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 514–521.

https://doi.org/10.1182/asheducation.V2015.1.514.3917878

Published: 2015

Journal Articles

Evolving diagnostic criteria for multiple myeloma

S. Vincent Rajkumar

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 272–278.

https://doi.org/10.1182/asheducation-2015.1.272

Published: 2015

Journal Articles

How can we improve on the already impressive results in pediatric ALL?

Angela Thomas

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 414–419.

https://doi.org/10.1182/asheducation-2015.1.414

Published: 2015

Journal Articles

Update in large cell lymphoma: understanding the pathology report

Eric D. Hsi

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 605–617.

https://doi.org/10.1182/asheducation-2015.1.605

Published: 2015

Journal Articles

The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling

David W. Scott, Christian Steidl

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 144–150.

https://doi.org/10.1182/asheducation-2014.1.144

Published: 2014

Journal Articles

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

Mohamed L. Sorror, Elihu Estey

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 21–33.

https://doi.org/10.1182/asheducation-2014.1.21

Published: 2014

NARROW

Novel agents and immune invasion in Hodgkin lymphoma

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Molecular profiling and management of mantle cell lymphoma

Measuring success: utility of biomarkers in sickle cell disease clinical trials and care

GVHD: biology matters

AL amyloidosis: from molecular mechanisms to targeted therapies

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Classification and risk assessment in AML: integrating cytogenetics and molecular profiling

Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies

Follicular lymphoma: are we ready for a risk-adapted approach?

Molecular monitoring in chronic myeloid leukemia—how low can you go?

Prognostic factors in follicular lymphoma: new tools to personalize risk

Sickle cell disease: an inherited thrombophilia

Hodgkin lymphoma in children and adolescents: improving the therapeutic index

Evolving diagnostic criteria for multiple myeloma

How can we improve on the already impressive results in pediatric ALL?

Update in large cell lymphoma: understanding the pathology report

The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only